September 1, 2023
Shionogi said on August 31 that its R&D project for nasal vaccines against influenza and COVID-19 has been selected under the funding program by SCARDA, or Japan’s Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response...read more